Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
Watch these stocks as they approach bullish 'golden cross' pattern, says technician Carter Worth
03:29pm, Wednesday, 19'th Jul 2023
Carter Worth, Worth Charting CEO, joins 'Power Lunch' to give his read on the technicals, looking at stocks on the verge of a breakout.
Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea
07:23pm, Wednesday, 05'th Jul 2023
Laboratory Corporation of America Holdings shares have been hurt by the boom-bust cycle induced by the pandemic. Tough comparables should run off in the coming quarters, as the company is simplifying
LabCorp (LH) Partners With Forge Biologics for Gene Therapies
11:32am, Wednesday, 05'th Jul 2023
LabCorp's (LH) latest partnership will significantly assist patients gain access to cutting-edge, potentially life-saving medication.
Labcorp (LH) Announces Completion of the Fortrea Spin-off
09:14am, Tuesday, 04'th Jul 2023
Labcorp (LH) completes the planned spin-off of Fortrea to operate as an independent clinical development business.
Why Shares of Labcorp Dropped Monday
12:59pm, Monday, 03'rd Jul 2023
While the spinoff deal is positive for Labcorp, investors used the opportunity to sell on the news. Labcorp will do a $1 billion stock repurchase program and pay down debt.
Labcorp spins off Fortrea contract research organization with stock debut on the Nasdaq
08:23am, Monday, 03'rd Jul 2023
Labcorp LH, +0.35% said Monday it completed the spin-off of Fortrea FTREV, -3.98% as an independent contract research organization (CRO) that specializes in Phase I-IV clinical trial management, patie
Labcorp to Announce Second Quarter Financial Results on July 27, 2023
07:03am, Thursday, 29'th Jun 2023
BURLINGTON, N.C. , June 29, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the second quarter of 2023 before the market opens
Laboratory Corporation: Predictability Of Cash Flows Less Visible
10:33pm, Tuesday, 20'th Jun 2023
Laboratory Corporation has visible headwinds to growth ahead. The company's return on capital employed has lagged behind the required rate of return in the last two periods. Net-net, reiterate that LH
LabCorp (LH) Gives Update as Fortrea Spinoff Nears Closure
12:28pm, Monday, 12'th Jun 2023
Fortrea is set to comprise Labcorp's (LH) Clinical Development and Commercialization Services businesses.
LabCorp (LH) Provides Update on Planned Spinoff of Fortrea
02:19pm, Wednesday, 07'th Jun 2023
After separation from LabCorp (LH), Fortrea is set to operate as a global contract research organization that offers comprehensive drug and medical device development services.
LabCorp (LH) Expands Precision Oncology With Biopsy Test
09:49am, Thursday, 01'st Jun 2023
The addition of Labcorp Plasma Focus marks a pivotal step in the expansion of LabCorp's (LH) suite of precision oncology tests.
3 No-Brainer Stocks to Buy in a Correction
06:32am, Friday, 26'th May 2023
NextEra Energy is a utility powerhouse, positioned to keep growing. Laboratory Corp. of America is a leader in diagnostic testing.
Why Is LabCorp (LH) Down 2.7% Since Last Earnings Report?
12:32pm, Thursday, 25'th May 2023
LabCorp (LH) reported earnings 30 days ago. What's next for the stock?
LabCorp (LH) Expands Laboratory Relationship With New Pact
03:52pm, Wednesday, 17'th May 2023
LabCorp's (LH) recent partnership will expand healthcare access, offer advanced diagnostic tools and guarantee that both patients and doctors can afford the treatments they get.
Here's Why Investors Should Retain LabCorp (LH) Stock for Now
03:57pm, Tuesday, 16'th May 2023
Investors are optimistic about LabCorp (LH) on strategic partnerships and upbeat guidance.
